永井宏和

ナガイヒロカズ | NAGAI HIROKAZU

所属機関・部署：

研究分野 (1件)：血液、腫瘍内科学

研究キーワード (3件)：臨床腫瘍学 , 悪例リンパ腫 , 血液内科

競争的資金等の研究課題 (4件)：

2011 - 2012 未治療多発性骨髄腫の初回治療における比較効果研究に関するメタアナリシス
2010 - 2012 p57KIP2遺伝子メチル化を指標とした悪性リンパ腫の予後予測モデルの開発
2007 - 2008 造血器腫瘍におけるp57KIP2遺伝子を中心とした発癌ネットワークの解析
2004 - 2005 癌抑制遺伝子としてのp57KIP2遺伝子の解析

論文 (142件)：

Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203. Hematological oncology. 2024. 42. 3. e3272
Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203. British Journal of Haematology. 2023
Michinori Ogura, Kazuhito Yamamoto, Yasuo Morishima, Masashi Wakabayashi, Kensei Tobinai, Kiyoshi Ando, Naokuni Uike, Mitsutoshi Kurosawa, Hiroshi Gomyo, Masafumi Taniwaki, et al. Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406. Cancer science. 2023. 114. 8. 3461-3465
Tomoki Naoe, Akiko Saito, Nahoko Hosono, Senji Kasahara, Hideharu Muto, Kaoru Hatano, Mizuki Ogura, Taro Masunari, Masatsugu Tanaka, Kensuke Usuki, et al. Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide. Cancer immunology, immunotherapy : CII. 2023. 1-7
Tomonori Kawasaki, Tomoaki Tashima, Atsushi Enomoto, Tetsuo Kondo, Hirokazu Nagai, Yasuhiro Nakamura, Jiro Ichikawa, Kiyomi Taniyama, Kyoichi Kaira. Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives. Virchows Archiv : an international journal of pathology. 2023. 482. 5. 929-930

MISC (40件)：

Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, et al. Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2022. 140. 11890-11892
Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma. BLOOD. 2022. 140. 3615-3617
亀位涼, 中嶋琢人, 坂部彩, 頭金正博, 李政樹, 飯田真介, 丸山大, 大佐賀智, 福原規子, 宮崎香奈, et al. ボルテゾミブの有害事象に関わるバイオマーカー候補HLAアリルの探索. 臨床薬理. 2020. 51. Suppl. S301-S301
Ken Takase, Hirokazu Nagai, Moe Kadono, Takanori Yoshioka, Nobuyuki Yoshio, Yukio Hirabayashi, Takuo Ito, Morio Sawamura, Akihiro Yokoyama, Shinichiro Yoshida, et al. High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura. International journal of hematology. 2020. 111. 3. 388-395
Ken Ohmachi, Tomohiro Kinoshita, Kensei Tobinai, Gakuto Ogawa, Tomonori Mizutani, Nobuhiko Yamauchi, Noriko Fukuhara, Toshiki Uchida, Kazuhito Yamamoto, Kana Miyazaki, et al. Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601. BLOOD. 2018. 132

学歴 (1件)：

- 現在金沢大学医学部医学科

経歴 (1件)：

- 現在国立病院機構名古屋医療センター血液・腫瘍研究部部長

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

永井 宏和

永井宏和